Literature DB >> 35763149

Use of deep learning to predict postoperative recurrence of lung adenocarcinoma from preoperative CT.

Yuki Sasaki1,2, Yohan Kondo3, Tadashi Aoki4, Naoya Koizumi5, Toshiro Ozaki5, Hiroshi Seki5.   

Abstract

PURPOSE: Although surgery is the primary treatment for lung cancer, some patients experience recurrence at a certain rate. If postoperative recurrence can be predicted early before treatment is initiated, it may be possible to provide individualized treatment for patients. Thus, in this study, we propose a computer-aided diagnosis (CAD) system that predicts postoperative recurrence from computed tomography (CT) images acquired before surgery in patients with lung adenocarcinoma using a deep convolutional neural network (DCNN).
METHODS: This retrospective study included 150 patients who underwent curative surgery for primary lung adenocarcinoma. To create original images, the tumor part was cropped from the preoperative contrast-enhanced CT images. The number of input images to the DCNN was increased to 3000 using data augmentation. We constructed a CAD system by transfer learning using a pretrained VGG19 model. Tenfold cross-validation was performed five times. Cases with an average identification rate of 0.5 or higher were determined to be a recurrence.
RESULTS: The median duration of follow-up was 73.2 months. The results of the performance evaluation showed that the sensitivity, specificity, and accuracy of the proposed method were 0.75, 0.87, and 0.82, respectively. The area under the receiver operating characteristic curve was 0.86.
CONCLUSION: We demonstrated the usefulness of DCNN in predicting postoperative recurrence of lung adenocarcinoma using preoperative CT images. Because our proposed method uses only CT images, we believe that it has the advantage of being able to assess postoperative recurrence on an individual patient basis, both preoperatively and noninvasively.
© 2022. CARS.

Entities:  

Keywords:  CT; Deep convolutional neural network; Lung adenocarcinoma; Postoperative recurrence; Prediction; Transfer learning

Mesh:

Year:  2022        PMID: 35763149     DOI: 10.1007/s11548-022-02694-0

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   3.421


  28 in total

Review 1.  Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes.

Authors:  David Fedor; W Rainey Johnson; Sunil Singhal
Journal:  Surg Oncol       Date:  2013-05-20       Impact factor: 3.279

Review 2.  Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures.

Authors:  Simona Carnio; Silvia Novello; Mauro Papotti; Marco Loiacono; Giorgio Vittorio Scagliotti
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.

Authors:  Noriyoshi Sawabata; Hisao Asamura; Tomoyuki Goya; Masaki Mori; Yoichi Nakanishi; Kenji Eguchi; Yoshihiko Koshiishi; Meinoshin Okumura; Etsuo Miyaoka; Yoshitaka Fujii
Journal:  J Thorac Oncol       Date:  2010-09       Impact factor: 15.609

4.  Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.

Authors:  Jiro Okami; Yasushi Shintani; Meinoshin Okumura; Hiroyuki Ito; Takashi Ohtsuka; Shinichi Toyooka; Takeshi Mori; Shun-Ichi Watanabe; Hiroshi Date; Kohei Yokoi; Hisao Asamura; Takeshi Nagayasu; Etsuo Miyaoka; Ichiro Yoshino
Journal:  J Thorac Oncol       Date:  2018-10-10       Impact factor: 15.609

5.  Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.

Authors:  Ryo Maeda; Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

6.  Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.

Authors:  Yoshihisa Shimada; Hisashi Saji; Koichi Yoshida; Masatoshi Kakihana; Hidetoshi Honda; Masaharu Nomura; Jitsuo Usuda; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

Review 7.  Lung cancer: current therapies and new targeted treatments.

Authors:  Fred R Hirsch; Giorgio V Scagliotti; James L Mulshine; Regina Kwon; Walter J Curran; Yi-Long Wu; Luis Paz-Ares
Journal:  Lancet       Date:  2016-08-27       Impact factor: 79.321

8.  A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

Authors:  Hisao Asamura; Tomoyuki Goya; Yoshihiko Koshiishi; Yasunori Sohara; Kenji Eguchi; Masaki Mori; Yohichi Nakanishi; Ryosuke Tsuchiya; Kaoru Shimokata; Hiroshi Inoue; Toshihiro Nukiwa; Etsuo Miyaoka
Journal:  J Thorac Oncol       Date:  2008-01       Impact factor: 15.609

9.  Risk factors for recurrence after lung cancer resection as estimated using the survival tree method.

Authors:  Shigeki Sawada; Natsumi Yamashita; Hiroshi Suehisa; Motohiro Yamashita
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.